Stay updated on Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.

Latest updates to the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice along with Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedAdded a site-wide notice about government funding and NIH Clinical Center operating status. Updated the site revision to v3.4.1 (removing v3.4.0).SummaryDifference0.2%

- Check51 days agoChange DetectedShow glossary control was added, and metadata labels were updated to reflect capitalization changes (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag now shows v3.4.0.SummaryDifference0.1%

- Check65 days agoChange DetectedThe site revision was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check86 days agoChange Detected- Added a new Locations section with listed states (California, Kentucky, Massachusetts, Michigan, North Carolina); removed the individual California Locations, Kentucky Locations, Massachusetts Locations, Michigan Locations, and North Carolina Locations subsections.SummaryDifference0.2%

Stay in the know with updates to Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.